Tags

Type your tag names separated by a space and hit enter

Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.
Am J Kidney Dis. 2008 Dec; 52(6):1051-60.AJ

Abstract

BACKGROUND

Effects of decreased estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) mortality are uncertain in Chinese general populations.

STUDY DESIGN

Prospective cohort study.

SETTING & PARTICIPANTS

17,026 adults 50 years and older in Taiwan. A subset of 7,968 had repeated measurements.

PREDICTOR

Decreased eGFR and its progression. eGFR was calculated from serum creatinine level by using the Modification of Diet in Renal Disease Study equation.

OUTCOMES

Mortality from all causes and CVD, including coronary heart disease (CHD) and stroke, from the National Death Registry.

MEASUREMENTS

Hazard ratios (HRs) and Kaplan-Meier survival curves were calculated for participants with a moderate to severe decrease in eGFR (<60 mL/min/1.73 m(2)) compared with those with normal eGFR (> or =90 mL/min/1.73 m(2)). HR of a rapid decrease (> or =20%) in eGFR was also calculated.

RESULTS

Mean age of all participants was 57.2 +/- 5.2 (SD) years. We observed 1,682 deaths in 15 years of follow-up. Participants with a moderate to severe decrease in eGFR had increased HRs for mortality from all causes (1.44; 95% confidence interval [CI], 1.22 to 1.70), CVD (1.90; 95% CI, 1.36 to 2.65), CHD (2.07; 95% CI, 1.26 to 3.41), and stroke (2.16; 95% CI, 1.29 to 3.62) after adjusting for confounders. Decreased eGFR was associated with ischemic stroke, but not hemorrhagic stroke. No significant interaction between decreased eGFR and anemia, diabetes, or smoking was found. There were 660 participants with a 20% or greater decrease in eGFR from baseline during 18 months of follow-up. They had increased HRs for all causes (1.45; 95% CI, 1.13 to 1.86), CVD (2.48; 95% CI, 1.58 to 3.89), CHD (2.14; 95% CI, 1.07 to 4.29), and stroke (2.79; 95% CI, 1.45 to 5.36) compared with those with less than a 20% decrease in eGFR during the same period.

LIMITATIONS

Data for proteinuria were not available. Creatinine assay was not calibrated.

CONCLUSIONS

A moderate to severe or fast decrease in eGFR was associated with all-cause and CVD mortality in this ethnic Chinese cohort.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Cheng TY
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Wen SF
No affiliation info available
Astor BC
No affiliation info available
Tao XG
No affiliation info available
Samet JM
No affiliation info available
Wen CP
No affiliation info available

MeSH

Cardiovascular DiseasesCause of DeathFemaleFollow-Up StudiesGlomerular Filtration RateHumansMaleMiddle AgedProspective StudiesRisk FactorsTaiwan

Pub Type(s)

Journal Article

Language

eng

PubMed ID

18706747

Citation

Cheng, Ting-Yuan David, et al. "Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan." American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, vol. 52, no. 6, 2008, pp. 1051-60.
Cheng TY, Wen SF, Astor BC, et al. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis. 2008;52(6):1051-60.
Cheng, T. Y., Wen, S. F., Astor, B. C., Tao, X. G., Samet, J. M., & Wen, C. P. (2008). Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 52(6), 1051-60. https://doi.org/10.1053/j.ajkd.2008.05.030
Cheng TY, et al. Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan. Am J Kidney Dis. 2008;52(6):1051-60. PubMed PMID: 18706747.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. AU - Cheng,Ting-Yuan David, AU - Wen,Sung-Feng, AU - Astor,Brad C, AU - Tao,Xuguang Grant, AU - Samet,Jonathan M, AU - Wen,Chi Pang, Y1 - 2008/08/15/ PY - 2007/12/15/received PY - 2008/05/12/accepted PY - 2008/8/19/pubmed PY - 2008/12/19/medline PY - 2008/8/19/entrez SP - 1051 EP - 60 JF - American journal of kidney diseases : the official journal of the National Kidney Foundation JO - Am J Kidney Dis VL - 52 IS - 6 N2 - BACKGROUND: Effects of decreased estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) mortality are uncertain in Chinese general populations. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 17,026 adults 50 years and older in Taiwan. A subset of 7,968 had repeated measurements. PREDICTOR: Decreased eGFR and its progression. eGFR was calculated from serum creatinine level by using the Modification of Diet in Renal Disease Study equation. OUTCOMES: Mortality from all causes and CVD, including coronary heart disease (CHD) and stroke, from the National Death Registry. MEASUREMENTS: Hazard ratios (HRs) and Kaplan-Meier survival curves were calculated for participants with a moderate to severe decrease in eGFR (<60 mL/min/1.73 m(2)) compared with those with normal eGFR (> or =90 mL/min/1.73 m(2)). HR of a rapid decrease (> or =20%) in eGFR was also calculated. RESULTS: Mean age of all participants was 57.2 +/- 5.2 (SD) years. We observed 1,682 deaths in 15 years of follow-up. Participants with a moderate to severe decrease in eGFR had increased HRs for mortality from all causes (1.44; 95% confidence interval [CI], 1.22 to 1.70), CVD (1.90; 95% CI, 1.36 to 2.65), CHD (2.07; 95% CI, 1.26 to 3.41), and stroke (2.16; 95% CI, 1.29 to 3.62) after adjusting for confounders. Decreased eGFR was associated with ischemic stroke, but not hemorrhagic stroke. No significant interaction between decreased eGFR and anemia, diabetes, or smoking was found. There were 660 participants with a 20% or greater decrease in eGFR from baseline during 18 months of follow-up. They had increased HRs for all causes (1.45; 95% CI, 1.13 to 1.86), CVD (2.48; 95% CI, 1.58 to 3.89), CHD (2.14; 95% CI, 1.07 to 4.29), and stroke (2.79; 95% CI, 1.45 to 5.36) compared with those with less than a 20% decrease in eGFR during the same period. LIMITATIONS: Data for proteinuria were not available. Creatinine assay was not calibrated. CONCLUSIONS: A moderate to severe or fast decrease in eGFR was associated with all-cause and CVD mortality in this ethnic Chinese cohort. SN - 1523-6838 UR - https://www.unboundmedicine.com/medline/citation/18706747/Mortality_risks_for_all_causes_and_cardiovascular_diseases_and_reduced_GFR_in_a_middle_aged_working_population_in_Taiwan_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272-6386(08)01006-8 DB - PRIME DP - Unbound Medicine ER -